Urography into the 21st century: New contrast media, renal handling, imaging characteristics, and nephrotoxicity

Radiology

Volumn 204, Issue 2, 1997, Pages 297-312

  Katzberg, Richard W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contrast media, complications; Contrast media, effects; Kidney, effects of drugs on; State of art reviews; Urography, contrast media

Indexed keywords

CONTRAST MEDIUM;

CONTRAST RADIOGRAPHY; DIAGNOSTIC IMAGING; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; NEPHROTOXICITY; PRIORITY JOURNAL; REVIEW; UROGRAPHY;

EID: 0030742750     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.204.2.9240511     Document Type: Review

References (163)

1. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996; 275:1489-1494.
2. Turney JH. Acute renal failure: a dangerous condition (editorial). JAMA 1996; 275:1516-1517.
3. Long L, Burger A. Synthesis of some iodinated aromatic compounds. J Am Chem Soc 1941; 63:1586-1591.
4. Wallingford V, Becker H, Kruty M. X-ray contrast media. I. Iodinated acylaminobenzoic acids. J Am Chem Soc 1952; 74:4365-4372.
5. Wallingford V. The development of organic iodine compounds as x-ray contrast media. J Am Pharm Assoc 1953; 42:721-729.
6. Almén T. Visipaque: a step forward - a historical review. Acta Radiol 1995; 36 (suppl 399):2-18.
7. Almén T. Contrast agent design: some aspects of synthesis of water-soluble contrast agents of low osmolality. J Theo Biol 1969; 24:216-226.
8. Spataro RF. Newer contrast agents for urography. Radiol Clin North Am 1984; 22:365-380.
9. Sovak M. New developments in radiographic contrast media. In: Parvez Z, ed. Contrast media: biologic effects and clinical applications. Boca Raton, Fla: CRC Press, 1987; 27.
10. McClennan BL. Low-osmolality contrast media: premises and promises. Radiology 1987; 162:1-8.
11. Katzberg RW. New and old contrast agents: physiology and nephrotoxicity. Urol Radiol 1988; 10:6-11.
12. McClennan BL. Ionic and nonionic iodinated contrast media: evolution and strategies for use. AJR 1990; 155:225-233.
13. Morris TW. X-ray contrast media: where are we now and where are we going? Radiology 1993; 188:11-16.
14. Sovak M. The Harry W. Fischer lecture: contrast media - a meandering look. Acad Radiol 1996; 3:5241-5247.
15. Lasser E, Farr RS, Fujimagari T, Tripp W. The significance of protein binding of contrast media in roentgen diagnosis. AJR 1962; 87:338-360.
16. Lang J, Lasser E. Nonspecific inhibition of enzymes by organic contrast media. J Med Chem 1971; 14:233-236.
17. Eloy R, Corot C, Belleville J. Contrast media for angiography: physicochemical properties, pharmacokinetics and biocompatibility. Clin Materials 1991; 7:89-197.
18. Narimatsu Y, Hiramatsu K. A Japanese multicenter comparison of iotrolan 280 with iopamidol in intravenous urography. Eur Radiol 1995; 5:S58-S62.
19. Dawson P. The non-ionic dimers: some theoretical and clinical considerations. Eur Radiol 1995; 5:S103-S106.
20. Aspelin P. Clinical experience of the use of a non-ionic dimeric contrast medium. Eur Radiol 1996; 6:S23-S26.
21. Deray G, Jacobs C. Renal tolerance of nonionic dimers. Invest Radiol 1996; 31: 372-377.
22. Sundgren PC, Bååth L, Törnquist C, Hougens Grynne B, Kjaersgaard P, Almén T. Image quality and safety after iodixanol in intravenous urography: a comparison with iohexol. Br J Radiol 1996; 69:699-703.
23. Sovak M, Ranganothan R, Lang J, Lasser EC. Concepts in design of improved intravascular contrast agents. Ann Radiol 1978; 21:283-289.
24. Sovak M. The need for improved contrast media: ioxilan and updating the design theory. Invest Radiol 1988; 23(suppl 1):S79-S83.
25. Dean PB, Kivisaari L, Kormano M. Contrast enhancement pharmacokinetics of six ionic and nonionic contrast media. Invest Radiol 1983; 18:368-374.
26. Nordby A, Tvedt KE, Halgunset J, Haugen OA. Intracellular penetration and accumulation of radiographic contrast media in the rat kidney. Scanning Microsc 1990; 4:651-666.
27. Jakobsen JÅ, Lundby B, Kristoffersen DT, et al. Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers. Radiology 1992; 182:419-424.
28. Dobrota M, Powell CJ, Holtz E, et al. Biochemical and morphological effects of contrast media on the kidney. Acta Radiol 1995; 36:196-203.
29. Jakobsen JÅ. Renal effects of iodixanol in healthy volunteers and patients with severe renal failure. Acta Radiol 1995; 36 (suppl 399):191-195.
30. Rapoport SI, Hori M, Klatzo I. Testing of a hypothesis for osmotic opening of the blood-brain barrier. Am J Physiol 1992; 223:323-331.
31. Rapoport SI, Levitan H. Neurotoxicity of x-ray contrast media: relation to lipid solubility and blood brain barrier permeability. AJR 1974; 122:186-194.
32. Levitan H, Rapoport SI. Contrast media: quantitative criteria for designing compounds with low toxicity. Acta Radiol Diagn 1976; 17:81-86.
33. Dean PB. Early pharmacokinetics of an intravascular contrast medium. Dissertation. University of Turku, Turku, Finland, 1977.
34. Newhouse JH. Fluid compartment distribution of intravenous iothalamate in the dog. Invest Radiol 1977; 12:364-367.
35. Burgener FA, Hamlin DJ. Contrast enhancement in abdominal CT: bolus versus infusion. AJR 1981; 137:351-358.
36. Morris TW, Fischer HW. The pharmacology of intravascular radiocontrast media. Ann Rev Pharmacol Toxicol 1986; 26:143-160.
37. Katzberg RW. The contrast media manual. Baltimore, Md: Williams & Wilkins 1992.
38. 131 and glomerular filtration in the dog. Am J Physiol 1963; 204:536-540.
39. Brenes LG, Forlano H, Koutouratsas N, Stauffer HM. Mechanism of the nephrographic effect during urinary stasis. Acta Radiol Diagn 1966; 4:14-20.
40. Denneberg T. Clinical studies of kidney function with radioactive sodium diatrizoate (Hypaque). Acta Med Scand 1966; 179(suppl 442):1-13.
41. Cattell WR, Fry IK, Spencer AG, Purkis P. Excretion urography. I. Factors determining the excretion of Hypaque. Br J Radiol 1967; 40:561-571.
42. Donaldson IM. Comparison of the renal clearance of inulin and radioactive diatrizoate (Hypaque) as measures of the glomerular filtration rate in man. Clin Sci 1968; 35:513-524.
43. Fry IK, Cattell WR. The nephrographic pattern during excretion urography. Br Med Bull 1972; 28:227-232.
44. Benness GT. Urographic contrast agents: a comparison of sodium and methyl glucamine salts. Clin Radiol 1973; 24:445-448.
45. Anigstein R, Elkin M, Roland P, Schulz RJ. The obstructive nephrogram: micro diagraphic studies. Invest Radiol 1972; 7:24-32.
46. Elkin M. Radiology of the urinary tract: some physiological considerations. Radiology 1975; 116:259-270.
47. Duré-Smith P. Urographic agents. In: Miller RE, Skucas J, eds. Radiographic contrast agents. Baltimore, Md: University Park Press, 1977; 273-306.
48. Mudge GH. The maximal urinary concentration of diatrizoate. Invest Radiol 1980; 15:S67-S78.
49. Donaldson IM. Comparison of the renal clearance of inulin and radioactive diatrizoate (Hypaque) as measures of the glomerular filtration rate in man. Clin Sci 1968; 35:513-524.
50. Lundqvist S, Edbom G, Groth S, et al. Iohexol clearance for renal functional measurement in gynecological cancer patients. Acta Radiol 1996; 37:582-585.
51. Frennby B, Sterner G. The use of iohexol to determine GFR in patients with severe chronic renal failure: a comparison between different clearance techniques. Clin Nephrol 1995; 43:35-36.
52. Frennby B, Sterner G, Almén T, et al. Extrarenal plasma clearance of iohexol, chromium-51-ethylenediamenetetraacetic acid, and inulin in anephric pigs. Acad Radiol 1996; 3:145-146.
53. Ackrill P, MacIntosh CS, Nimmon C, et al. A comparison of the clearance of urographic contrast medium (sodium diatrizoate) by peritoneal and hemodialysis. Clin Sci 1976; 50:69-74.
54. Waaler A, Svalin DM, Fairchild P, et al. Elimination of iohexol, a low osmolar non-ionic contrast medium by hemodialysis in patients with chronic renal failure. Nephron 1990; 56:81-85.
55. Bakris GL. Pathogenesis and therapeutic aspects of radiocontrast-induced renal disfunction. In: Hook JB, Goldstein RS, eds. Toxicology of the kidney. 2nd ed. New York, NY: Raven, 1993; 361-386.
56. Bahlmann J, Krüskemper HL. Elimination of iodine-containing contrast media by hemodialysis. Nephron 1973; 19:250-255.
57. Ackrill P, MacIntosh CS, Nimmens C, et al. Comparison of the clearance of urographic contrast medium (sodium diatrizoate) by peritoneal and hemodialysis. Clin Sci 1976; 50:69-74.
58. Milman N, Kristensen E. The elimination of diatrizoate by peritoneal dialysis in renal failure. Acta Radiol 1974; 15:265-272.
59. Younathan CM, Kande JV, Cook MD, et al. Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. AJR 1994; 163:969-971.
60. Ganong WF. Review of medical physiology. 10th ed. Los Altos, Calif: Lange Medical, 1981; 549-551.
61. Pitts RF. Physiology of the kidney and body fluids. 2nd ed. Chicago, Ill: Year Book Medical Publishers, 1968.
62. Gennari FJ, Kassires JP. Osmotic diuresis. N Engl J Med 1974; 291:714-720.
63. Dorph S, Sovak M, Talner LB, Rosen L. Why does kidney size change during IV urography? Invest Radiol 1977; 12:246-250.
64. Katzberg RW, Pabico RC, Morris TW, et al. Effects of contrast media on renal function and sub-cellular morphology in the dog. Invest Radiol 1986; 21:64-70.
65. Gottschalk CW, Mylle M. Micropuncture study of pressures in proximal and distal tubules and peritubular capillaries of the rat kidney during osmotic diuresis. Am J Physiol 1957; 189:323-328.
66. Katzberg RW, Schulman G, Meggs L, et al. Mechanism of the renal response to contrast medium in dogs: decrease in renal function due to hypertonicity. Invest Radiol 1983; 18:74-80.
67. Katzberg RW, Morris TW, Burgener FA, et al. Renal renin and hemodynamic responses to selective renal artery catheterization and angiography. Invest Radiol 1977; 12:381-388.
68. Katzberg RW, Donahue LA, Morris TW, et al. Ioxilan, a third generation low osmolality nonionic contrast medium: systemic and renal hemodynamic effects. Invest Radiol 1990; 25:46-51.
69. Dorph S. The effects of contrast agents on renal function. Eur Radiol 1995; 5: S74-S78.
70. Katzberg RW, Morris TW, Schulman G, et al. Reaction to intravenous contrast media. II. Acute renal response in euvolemic and dehydrated dogs. Radiology 1983; 147:331-334.
71. Ueda J. Effect of contrast media on single nephron functions. Thesis. Uppsala University, Uppsala, Sweden, 1991.
72. Braedel HU, Schindler E, Cullen P, Hoene E. Demonstration of residual contrast medium in the renal parenchyma using computerized tomography. J Urol 1987; 137:11-14.
73. Ishikawa I, Sato Y, Onouchi Z, et al. Delayed contrast enhancement in acute focal bacterial nephritis: CT features. J Comput Assist Tomogr 1985; 9:894-897.
74. Love L, Olsen MC. Persistent CT nephrogram: significance in the diagnosis of contrast nephropathy - an update. Urol Radiol 1991; 12:206-210.
75. Moreau JF, Droz D, Noel LH, et al. Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 1980; 15(suppl):554-560.
76. Maunspach AD, Sydney MK, Madden SC, Latta H. Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose or dextran. Lab Invest 1962; 11:421-426.
77. Sherwood T, Dollery CT, Breckenridge A. What is the nephrogram (letter)? Lancet 1967; 1:784.
78. Duré-Smith P, Simenhoff M, Brodsky S, Zimskind PD. Physiology of excretory urography. II. Concentration vs amount of contrast medium. Invest Radiol 1972; 7:407-410.
79. Spataro RF, Fischer HW, Boylan L. Urography with low osmolality contrast media: comparative urinary excretion of iopamidol, Hexabrix, and diatrizoate. Invest Radiol 1982; 17:494-500.
80. Duré-Smith P, Rosen R, Stern A, Fraimow H, Simenhoff M. Physiology of excretory urography. III. A densitometric and subjective assessment of changes in contrast medium concentration. Invest Radiol 1974; 9:104-108.
81. Brennan RE, Curtis JA, Pollack HM, Weinburg I. Sequential changes in CT numbers of the normal canine kidney following intravenous contrast administration. II. The renal medulla. Invest Radiol 1979; 14:239-245.
82. Brennan RE, Rapoport S, Weinberg I, Pollack HM, Curtis JA. CT-determined canine kidney and urine iodine concentrations following intravenous administration of sodium diatrizoate, metrizamide, iopamidol, and sodium ioxaglate. Invest Radiol 1982; 17:95-100.
83. Spataro RF, Katzberg RW, Fischer HW, McMannis MJ. High dose clinical urography with the low-osmolality contrast agent Hexabrix: comparison with a conventional contrast agent. Radiology 1987; 162:9-14.
84. Grainger RG. Renal toxicity of radiologic contrast media. Br Med Bull 1972; 28:191-195.
85. Van Zee BF, Hoy WE, Talley TE, Jaenike JR. Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients. Ann Intern Med 1978; 89:51-54.
86. Krumlousky FA, Simon N, Santhoram S, et al. Acute renal failure: association with administration of radiologic contrast media. JAMA 1978; 239:125-129.
87. Byrd L, Sherman RL. Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine 1979; 58:270-279.
88. Mudge GH. Nephrotoxicity of urographic radiocontrast drugs. Kidney Int 1980; 18:540-552.
89. D'Elia JA, Gleason R, Alday M, et al. Nephrotoxicity from angiographic contrast material: a prospective study. Am J Med 1982; 72:719-725.
90. Marx M, Bettman MA. Contrast induced renal failure. Postgrad Radiol 1985; 5:343-347.
91. Humes HD, Weinberg JM. Toxic nephropathies. In: Brenner BM, Rector FC Jr, eds. The kidney. 3rd ed. Philadelphia, Pa: Saunders, 1986; 1508-1509.
92. Berkseth RO, Kjellstrand CM. Radiologic contrast-induced nephropathy. Med Clin North Am 1984; 68:351-370.
93. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. AJR 1985; 136:859-863.
94. Gomes AS, Baker JD, Martin-Paredero V, et al. Acute renal dysfunction after major angiography. AJR 1985; 145:1249-1253.
95. Cruz C, Hricak H, Samhouri F, et al. Contrast media for angiography: effect on renal function. Radiology 1986; 158: 109-112.
96. Gomes AS, Lois JF, Baker JD, et al. Acute renal dysfunction in high risk patients after angiography: comparison of ionic and nonionic contrast media. Radiology 1989; 170:65-68.
97. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989; 320:143-149.
98. Schwab SJ, Hlatky MA, Pieper KS, et al. Contrast nephrotoxicity: a randomized controlled trial of nonionic and an ionic radiographic contrast agent. N Engl J Med 1989; 320:149-153.
99. Taliercio CP, Vlietstra RE, Ilstrup DM, et al. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol 1991; 17:384-390.
100. Barrett BJ, Carlisle E. A meta-analysis of the relative nephrotoxicity of high and low-osmolality contrast media. J Am Soc Nephrol 1992; 3:719.
101. Hill JA, Winniford M, Van Possen DB, et al. Nephrotoxicity following cardiac angiography: a randomized double-blind multicenter trial of ionic and nonionic contrast media in 1194 patients. Circulation 1991; 84:11-33.
102. Berns JS, Rudnick MR. Radiocontrast media associated nephrotoxicity. Kidney 1992; 24:1-5.
103. Porter GA. Effects of contrast agents on renal function. Invest Radiol 1993;28:S1-S5.
104. Goldfarb S, Spinler S, Berns JS, Rudnick MR. Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity. Invest Radiol 1993; 28:S7-S10.
105. Cohan RH, Dunnick NR. Intravascular contrast media: adverse reactions. AJR 1987; 149:665-670.
106. Fong LS, Sirota RA, Ebert TH, Lichtenstein NS. Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med 1980; 140: 531-533.
107. Katholi RE, Taylor GJ, Woods WT, et al. Nephrotoxicity of nonionic low osmolality contrast media: a prospective double-blind randomized comparison in human beings. Radiology 1993; 186:183-187.
108. Dachman AH. New contraindications to intravascular iodinated contrast material. Radiology 1995; 197:545.
109. Pond GD, Smyth SH, Roach DJ, Hunter G, et al. Metformin in contrast media: genuine risk or witch hunt (letter). Radiology 1996; 201:879-880.
110. Hostetter TH, Wilkes BM, Brenner BM. Mechanisms of impaired glomerular filtration in acute renal failure. In: Brenner BM, Stein JH, eds. Contemporary issues in nephrology. 6th ed. New York, NY: Churchill-Livingstone, 1980; 52-78.
111. Talner LB, Davidson AJ. Renal hemodynamic effects of contrast media. Invest Radiol 1968; 3:310-317.
112. Caldicott WJH, Hollenberg NK, Abrams HL. Characteristics of response of the renal vascular bed to contrast media. Invest Radiol 1970; 5:539-547.
113. Sherwood T, Lavender JP. Does renal blood flow rise or fall in response to diatrizoate? Invest Radiol 1969; 5:327-328.
114. Katzberg RW, Meggs LG, Schulman G, Hollenberg NK. Contrast medium-induced renal vasoconstriction and endogenous vasoconstrictor hormones. Br J Radiol 1982; 55:266-268.
115. Morcos SK, Brown PWG, Oldroyd S, et al. Relationship between the diuretic effect of radiocontrast media and their ability to increase renal vascular resistance. Br J Radiol 1995; 68:850-853.
116. Bakris GL, Burnett JC. A role for calcium in radiocontrast reduction in renal hemodynamics. Kidney Int 1985; 27:465-468.
117. Osswald H, Spielman WS, Knox FG. Mechanism of adenosine-mediated decreases in glomerular filtration rate. Circ Res 1978; 43:465-469.
118. Spielman WS, Thompson CI. A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol 1982; 242:F423-F435.
119. Hall JE, Granger JP, Hester RI. Interactions between adenosine and angiotensin II in controlling glomerular filtration. Am J Physiol 1985; 248:F340-346.
120. Arend LJ, Bakris GL, Burnett JC Jr, et al. Role of intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987; 110:406-411.
121. Erley CM, Duda SH, Schlepckow S, et al. Adenosine antagonist theophylline prevents the reduction in glomerular filtration rate after contrast media application. Kidney Int 1994; 45:1425-1431.
122. Katholi RE, Taylor GJ, McCann WP, et al. Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 1995; 195:17-22.
123. Gandhi MR, Brown P, Romanowski CAJ, et al. The use of theophylline, an adenosine antagonist in the prevention of contrast medium-induced nephrotoxicity (letter). Br J Radiol 1992; 65:838.
124. Drescher P, Pereira F, Will JA, Madsen PO. Nephrotoxicity from contrast media: attenuation with theophylline (letter). Radiology 1995; 197:547-548.
125. Morcos SK, Brown PWG. Nephrotoxicity from contrast media: attenuation with theophylline (letter). Radiology 1995; 197:546-547.
126. Yanagisawa M, Kuriahara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
127. Simonson MS. Endothelius: multifunctional renal peptides. Physiol Rev 1993; 73:375-411.
128. Clark BA, Heyman SN, Spokes K, et al. Rise in plasma endothelin produced by radiocontrast agents (abstr). J Am Soc Nephrol 1990; 1:412.
129. Lanese DM, Yuan BH, McMartry IF, Conger JD. Comparative sensitivities of isolated rat renal arterioles to endothelin. Am J Physiol 1992; 263:F894-F899.
130. Heyman SN, Clark BA, Kaiser N, et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992; 3:58-65.
131. Margulies KB, Hildebrand FL, Heublein DM, Burnett JC Jr. Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 1991; 2:1041-1045.
132. Margulies KB, McKinley LJ, Burnett JC. Endothelin in human and canine radiocontrast-induced nephropathy. J Vasc Res 1992; 29:163-164.
133. Oldroyd S, Slee SJ, Haylor J, Morcos SK, Wilson C. Role for endothelin in the renal responses to radiocontrast media in the rat. Clin Sci 1994; 87:427-434.
134. Brown P, Haylor J, Morcos SK, et al. Effect of diatrizoate on the function of the isolated perfused rat's kidney. Br J Radiol 1992; 65:1011-1017.
135. Oldroyd S, Haylor J, Morcos SK. The acute effect of ioversol on kidney function: the role of endothelin. Eur J Radiol 1995; 19:91-95.
136. A receptor. Life Sci 1992; 50:247-251.
137. Oldroyd SD, Haylor JL, Morcos SK. Bosentan, an orally active endothelin antagonist: effect on the renal response to contrast media. Radiology 1995; 196:661-665.
138. Nygren A, Ulfendahl HR, Hansell P, Erikson U. Effects of intravenous contrast media on cortical and medullary blood flow in the rat kidney. Invest Radiol 1988; 23:753-761.
139. Heyman SN, Brezis M, Epstein FH, et al. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991; 40:632-642.
140. Lis P. Effects of contrast media in renal microcirculation and oxygen tension: an experimental study in the rat. Thesis. Uppsala University, Uppsala, Sweden, 1996.
141. Lis P, Nygren A, Olsson U, et al. Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int 1996; 49:1268-1273.
142. Osswald H, Muhlbauer B, Schenk F. Adenosine mediates tubuloglomerular feedback response: an element of metabolic control of kidney function. Kidney Int 1991; 39:S128-S131.
143. Pabico RC, Katzberg RW, McKenna BA, et al. Hypertonic radiocontrast medium and the kidney: effects on renal functions in the envolemic and in the dehydrated dogs. In: Boch PH, Lock EA, eds. Nephrotoxicity. New York, NY: Plenum, 1989; 485-489.
144. Dibona GF. Effect of an ionic and non-ionic media on renal extraction of paraaminohippurate in the dog. Proc Exp Biol Med 1978; 157:453-455.
145. Talner LB, Davidson AJ. Effect of contrast media on renal function of PAH. Invest Radiol 1968; 3:301-309.
146. Humes HD, Hunt DA, White MD. Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. Am J Physiol 1987; 252:F246-F255.
147. Bartels ED, Brun GC, Gammeltoft A, Gjorup PA. Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand 1954; 40:297-302.
148. Meyers GH Jr, Witten DM. Acute renal failure after excretory urography in multiple myeloma. AJR 1973; 113:583-589.
149. Perillie PE, Conn HD. Acute renal failure after intravenous pyelography in plasma cell myeloma. JAMA 1958; 167: 2186-2189.
150. Harkonen S, Kjelstrand C. Contrast nephropathy. Am J Nephrol 1981; 7:69-77.
151. Berdon WE, Schwartz RH, Becker J, Baker DH. Tamm-Horsefall proteinuria: its relationship to prolonged nephrogram in infants and children and to acute renal failure following intravenous urography in adults with multiple myeloma. Radiology 1969; 92:714-718.
152. Tejler L, Almén T, Holtas S. Proteinuria following nephroangiography. I. Clinical experiences. Acta Radiol Diagn 1980; 21:491-494.
153. Holtas S, Almén T, Hellsten S, Tejler L. Proteinuria following nephroangiography. VI. Comparison between metrizoate and metrizamide in man. Acta Radiol Diagn 1980; 21:491-494.
154. Hartman HG. Enzymuria after water-soluble x-ray contrast media. In: Taenzer V, Zeitler E, eds. Contrast media. Stuttgart, Germany: Thieme, 1983; 30-36.
155. Parvez Z, Romanurstly S, Patel NB, Moncada R. Enzyme markers of contrast media-induced renal failure. Invest Radiol 1990; 25:S133-S134.
156. Naidu SG, Lee FT Jr. Contrast nephrotoxicity: predictive value of urinary enzyme markers in a rat model. Acad Radiol 1994; 1:3-9.
157. Solomon R, Warner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosamide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331:1416-1420.
158. Davidson CJ, Latky M, Morris KG, et al. Cardiovascular and renal toxicity of non-ionic radiographic contrast agent after cardiac catheterization: a prospective trial. Ann Intern Med 1989; 110:119-124.
159. 2+ and radiocontrast-reduced reductions in renal hemodynamics. Kidney Int 1985; 27:465-468.
160. Neumayer HH, Jung E, Küfner A, Winning A. Prevention of radiocontrast media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomized clinical trial. Nephrol Dial Transplant 1989; 4:1030-1036.
161. Hans B, Hans SS, Mittal VK, et al. Renal functional response to dopamine during and after arteriography in patients with chronic renal failure. Radiology 1990; 176:631-654.
162. Weisberg DS, Kunick PB, Kunick BRC. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Ren Fail 1993; 15:61-68.
163. Older RA, Korobkin M, Cleeve DM, et al. Contrast-induced acute renal failure: persistent nephrogram as clue to early detection. AJR 1980; 13:339-343.